Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2012, Vol. 10 ›› Issue (5): 555-560.doi: 10.3736/jcim20120511

• Original Experimental Research • Previous Articles     Next Articles

Protective effect of Heliotropium eichwaldi against cisplatin-induced nephrotoxicity in mice

Surendra Kr. Sharma(), Naveen Goyal#br#   

  1. Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar 125001, Haryana, IndiaDepartment of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar 125001, Haryana, India
  • Received:2011-12-05 Accepted:2012-02-15 Online:2012-05-20 Published:2018-06-15
  • Contact: Kr. Sharma Surendra

Objective: The aim of the present study was to evaluate the nephroprotective effect of methanolic extract of Heliotropium eichwaldii (MHE) in mice with cisplatin-induced acute renal damage.

Methods: Nephrotoxicity was induced by a single intraperitoneal injection of cisplatin (16 mg/kg). Swiss albino mice were injected with vehicle, cisplatin, cisplatin plus MHE 200 mg/kg and cisplatin plus MHE 400 mg/kg, respectively. MHE was administered for 7 d at a dose of 200 and 400 mg/kg per day orally starting 4 d before cisplatin injection. Animals were sacrificed 3 d after treatment and blood as well as kidney tissue was isolated and analyzed. The various parameters such as blood urea nitrogen (BUN), serum creatinine (CRE), malondialdehyde (MDA), and catalase (CAT) and superoxide dismutase (SOD) activities were analyzed.

Results: MHE treatment significantly reduced BUN and serum CRE levels elevated by cisplatin administration (P<0.05). Also, it significantly attenuated cisplatin-induced increase in MDA level and improved the decreased CAT and SOD activities in renal cortical homogenates (P<0.05). Additionally, histopathological examination and scoring showed that MHE markedly ameliorated cisplatin-induced renal tubular necrosis.

Conclusion: MHE can be considered a potential candidate for protection of nephrotoxicity induced by cisplatin.

Key words: Heliotropium, plant extracts, cisplatin, antioxidant, nephrotoxicity, mice


Group n BUN CRE
Normal control 6 360.0±23.0 6.0±0.4
Model control (vehicle plus cisplatin (16 mg/kg)) 6 2 340.0±116.0* 38.6±2.3*
MHE (200 mg/kg) plus cisplatin (16 mg/kg) 6 1 340.0±114.0 18.8±1.1
MHE (400 mg/kg) plus cisplatin (16 mg/kg) 6 960.0±63.0 9.3±0.8


Group n MDA (nmol/mg protein) SOD (U/mg protein) CAT (U/mg protein)
Normal control 6 0.36±0.03 46.3±3.3 13.3±1.0
Model control (vehicle plus cisplatin (16 mg/kg)) 6 0.92±0.08* 19.2±1.3* 6.1±0.5*
MHE (200 mg/kg) plus cisplatin (16 mg/kg) 6 0.81±0.07 28.6±3.1 8.6±0.7
MHE (400 mg/kg) plus cisplatin (16 mg/kg) 6 0.45±0.03 39.2±2.5 11.8±0.9

Figure 1

Photomicrographs of kidney tissues stained by hematoxylin and eosin (Light microscopy, ×100) A: Normal control group; B: Cisplatin plus vehicle-treated group showing tubular necrosis; C: Cisplatin plus MHE (400 mg/kg)-treated group displaying improvement in the histological appearance with marked reduction in tubular damage. MHE: methanolic extract of Heliotropium eichwaldi."


Group n Score
Normal control 6 0+
Model control (vehicle plus cisplatin (16 mg/kg)) 6 3+
MHE (200 mg/kg) plus cisplatin (16 mg/kg) 6 2+
MHE (400 mg/kg) plus cisplatin (16 mg/kg) 6 1+
[1] Joy J, Nair CK . Amelioration of cisplatin induced nephrotoxicity in Swiss albino mice by Rubia cordifolia extract[J]. J Cancer Res Ther, 2008,4(3):111-115.
doi: 10.4103/0973-1482.43139
[2] Lebwohl D, Canetta R . Clinical development of platinum complexes in cancer therapy: an historical perspective and an update[J]. Eur J Cancer, 1998,34(10):1522-1534.
doi: 10.1016/S0959-8049(98)00224-X
[3] Madias NE, Harrington JT . Platinum nephrotoxicity[J]. Am J Med, 1978,65(2):307-314.
doi: 10.1016/0002-9343(78)90825-2
[4] Taguchi T, Nazneen A, Abid MR, Razzaque MS . Cisplatin-associated nephrotoxicity and pathological events[J].Contrib Nephrol, 2005, 148: 107-121.
doi: 10.1159/000086055 pmid: 15912030
[5] Bodenner DL, Dedon PC, Keng PC, Katz JC, Borch RF . Selective protection against cis-diamminedichloroplatinum(Ⅱ)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate[J]. Cancer Res, 1986,46(6):2751-2755.
[6] Babu E, Gopalakrishnan VK, Sriganth IN, Gopalakrishnan R, Sakthisekaran D . Cisplatin induced nephrotoxicity and the modulating effect of glutathione ester[J]. Mol Cell Biochem, 1995,144(1):7-11.
doi: 10.1007/BF00926734 pmid: 7791748
[7] Chirino YI, Pedraza-Chaverri J . Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity[J]. Exp Toxicol Pathol, 2009,61(3):223-242.
doi: 10.1016/j.etp.2008.09.003 pmid: 18986801
[8] Ali BH, Al Moundhri MS . Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research[J]. Food Chem Toxicol, 2006,44(8):1173-1183.
doi: 10.1016/j.fct.2006.01.013
[9] Jain SC, Sharma R . Antimicrobial activity of pyrrolizidine alkaloids from Heliotropium ellipticum. Chem Pharm Bull (Tokyo). 1987; 35(8):3487-3489.
doi: 10.1248/cpb.35.3487 pmid: 3427725
[10] Reina M, Gonzalez-Coloma A, Gutierrez C, Cabrera R, Henriquez J, Villarroel L . Bioactive saturated pyrrolizidine alkaloids from Heliotropium floridum. Phytochemistry. 1997; 46(5):845-853.
doi: 10.1016/S0031-9422(97)00354-3
[11] Rastoqi RP, Mehrotra BN . A compendium on Indian medicinal plants. Vol 2. New Delhi and Lucknow: Publications & Information Directorate . 1991.
[12] Chopra RN, Nayar SL, Chopra IC . Glossary of Indian medicinal plants. 3rd ed. New Delhi: Council of Scientific & Industrial Research. 1956.
[13] Kirtikar KR, Basu BD . Indian medicinal plants. 2nd ed. Dehradun: International Book Distributors. 1991.
[14] Bhakuni DS, Dhar ML, Dhar MM, Dhawan BN, Mehrotra BN . Screening of Indian plants for biological activity. Ⅱ. Indian[J] Exp Biol. 1969; 7(4):250-262
[15] Gupta SK, Mathur IS . The effect of Arnebia nobilis and its naphthaquinones in rat Walker carcinosarcoma 256[J]. Indian J Cancer, 1972,9(1):50-55.
pmid: 5044709
[16] Jain SC, Singh B . Bioefficacy of Heliotropium ellipticum Ledeb. Ⅰ. Antimicrobial screening[J]. Indian J Pharm Sci, 1998,60(6):394-396.
[17] Sheena N, Ajith TA, Janardhanan KK . Prevention of nephrotoxicity induced by the anticancer drug cisplatin, using Ganoderma lucidum, a medicinal mushroom occurring in South India[J]. Curr Sci, 2003,85(4):478-482.
[18] Varley H, Gowenlock Alen H , Bell M. Practical clinical biochemistry.5th ed[M].London: William Heinmamm Medical Books Ltd, 1980: 456-460, 478-480.
[19] Ohkawa H, Ohishi N, Yagi K . Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction[J]. Anal Biochem, 1979,95(2):351-358.
doi: 10.1016/0003-2697(79)90738-3
[20] McCord JM, Fridovich I . Superoxide dismutase. An enzymic function for erythrocuprein(hemocuprein)[J]. J Biol Chem, 1969,244(22):6049-6055. x
[21] Beers RF Jr, Sizer IW . A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase[J]. J Biol Chem, 1952,195(1):133-140.
[22] Aebi H.Catalase in vitro[J].Methods Enzymol, 1984, 105: 121-126.
doi: 10.1016/S0076-6879(84)05016-3
[23] Ramesh G , Reeves WB.p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice[J]. Am J Physiol Renal Physiol, 2005,289(1):F166-F174.
doi: 10.1152/ajprenal.00401.2004 pmid: 15701814
[24] Yao X, Panichpisal K, Kurtzman N, Nugent K . Cisplatin nephrotoxicity: a review[J]. Am J Med Sci, 2007,334(2):115-124.
doi: 10.1097/MAJ.0b013e31812dfe1e
[25] Hannemann J, Baumann K . Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: different effects of antioxidants and radical scavengers[J]. Toxicology, 1988,51(2-3):119-132.
doi: 10.1016/0300-483X(88)90143-6
[26] Uslu R, Bonavida B . Involvement of the mitochondrion respiratory chain in the synergy achieved by treatment of human ovarian carcinoma cell lines with both tumor necrosis factor-α and cis-diamminedichloroplatinum[J]. Cancer, 1996,77(4):725-732.
doi: 10.1002/(ISSN)1097-0142
[1] Dona Nirmani Ann Wijewickrama Samarakoon, Deepthi Inoka Uluwaduge, Malith Aravinda Siriwardhene. Mechanisms of action of Sri Lankan herbal medicines used in the treatment of diabetes: A review. Journal of Integrative Medicine, 2020, 18(1): 13-20.
[2] Syed Fairus, Hwee Ming Cheng, Kalyana Sundram. Antioxidant status following postprandial challenge of two different doses of tocopherols and tocotrienols. Journal of Integrative Medicine, 2020, 18(1): 68-79.
[3] Gaëtan Olivier Fankem, Michel Archange Fokam Tagne, Paul Aimé Noubissi, Angèle Foyet Fondjo, Idrice Kamtchouing, Adela Ngwewondo, Henri Wambe, Joseph Ngakou Mukam, René Kamgang. Antioxidant activity of dichloromethane fraction of Dichrocephala integrifolia in Salmonella typhi-infected rats. Journal of Integrative Medicine, 2019, 17(6): 438-445.
[4] Rabie Kachkoul, Tarik Squalli Housseini, Mohamed Mohim, RadouaneEl Habbani, Youssef Miyah, Anissa Lahrichi. Chemical compounds as well as antioxidant and litholytic activities of Arbutus unedo L. leaves against calcium oxalate stones. Journal of Integrative Medicine, 2019, 17(6): 430-437.
[5] Yi Ran Hu, San Li Xing, Chuan Chen, Ding Zhu Shen, Jiu Lin Chen. Tiaoxin Recipe, a Chinese herbal formula, inhibits microRNA-34a expression in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease. Journal of Integrative Medicine, 2019, 17(6): 404-409.
[6] Stefania Lamponi, Anna Maria Aloisi, Claudia Bonechi, Marco Consumi, Alessandro Donati, Gemma Leone, Claudio Rossi, Gabriella Tamasi, Luana Ghiandai, Ersilia Ferrini, Paolo Fiorenzani, Ilaria Ceccarelli, Agnese Magnani. Evaluation of in vitro cell and blood compatibility and in vivo analgesic activity of plant-derived dietary supplements. Journal of Integrative Medicine, 2019, 17(3): 213-220.
[7] Fatma Mohamed Hussein Shediwah, Khalid Mohammed Naji, Hussein Saleh Gumaih, Fatima A Alhadi, Amani Lutf Al-Hammami, Myrene Roselyn D'Souza. Antioxidant and antihyperlipidemic activity of Costus speciosus against atherogenic diet-induced hyperlipidemia in rabbits. Journal of Integrative Medicine, 2019, 17(3): 181-191.
[8] Lucky Legbosi Nwidu, Yibala Ibor Oboma. Telfairia occidentalis (Cucurbitaceae) pulp extract mitigates rifampicin-isoniazid-induced hepatotoxicity in an in vivo rat model of oxidative stress. Journal of Integrative Medicine, 2019, 17(1): 46-56.
[9] Khaled M. M. Koriem, Mahmoud S. Arbid, Hend N. Saleh . Antidiarrheal and protein conservative activities of Psidium guajava in diarrheal rats. Journal of Integrative Medicine, 2019, 17(1): 57-65.
[10] Rohitash Jamwal. Bioavailable curcumin formulations: A review of pharmacokinetic studies in healthy volunteers. Journal of Integrative Medicine, 2018, 16(6): 367-374.
[11] Supakanya Kumkarnjana, Rutt Suttisri, Ubonthip Nimmannit, Thongchai Koobkokkruad, Chutichot Pattamadilok, Nontima Vardhanabhuti . Anti-adipogenic effect of flavonoids from Chromolaena odorata leaves in 3T3-L1 adipocytes. Journal of Integrative Medicine, 2018, 16(6): 427-434.
[12] Shohini Chakraborty, Nashra Afaq, Neelam Singh, Sukanta Majumdar. Antimicrobial activity of Cannabis sativaThuja orientalis and Psidium guajava leaf extracts against methicillin-resistant Staphylococcus aureus. Journal of Integrative Medicine, 2018, 16(5): 350-357.
[13] The Su Moe, Htet Htet Win, Thin Thin Hlaing, War War Lwin, Zaw Min Htet, Khin Mar Mya . Evaluation of in vitro antioxidant, antiglycation and antimicrobial potential of indigenous Myanmar medicinal plants. Journal of Integrative Medicine, 2018, 16(5): 358-366.
[14] Bruno José Martins Da Silva, Amanda Anastácia Pinto Hage, Edilene Oliveira Silva, Ana Paula Drummond Rodrigues. Medicinal plants from the Brazilian Amazonian region and their antileishmanial activity: A review. Journal of Integrative Medicine, 2018, 16(4): 211-222.
[15] Carola Analía Torres, Cristina Marisel Pérez Zamora, María Beatriz Nuñez, Ana María Gonzalez. In vitro antioxidant, antilipoxygenase and antimicrobial activities of extracts from seven climbing plants belonging to the Bignoniaceae. Journal of Integrative Medicine, 2018, 16(4): 255-262.
Full text



[1] Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[2] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[3] Jun Cai, Hua Wang, Sheng Zhou, Bin Wu, Hua-rong Song, Zheng-rong Xuan. Effect of Sijunzi Decoction and enteral nutrition on T-cell subsets and nutritional status in patients with gastric cancer after operation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2008, 6(1): 37-40
[4] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[5] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[6] Hai-feng Wei, Bai-liu Ya, Ling Zhao, Cui-fei Ye, Li Zhang, Lin Li. Evaluation of tongue manifestation of blood stasis syndrome and its relationship with blood rheological disorder in a rat model of transient brain ischemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 73-76
[7] A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82
[8] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. Guiding principles of clinical research on mild cognitive impairment (protocol). Journal of Chinese Integrative Medicine, 2008, 6(1): 9-14
[9] Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013
[10] Bo Wang , Wei Yan , Li-hui Hou, Xiao-ke Wu. Disorder of Tiangui (kidney essence) and reproductive dysfunction in patients with polycystic ovary syndrome. Journal of Chinese Integrative Medicine, 2010, 8(11): 1018-1022